Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin

Cancer Research

Volumn 63, Issue 5, 2003, Pages 951-957

  Cover, Timothy L ^a,b   Krishna, Uma S ^a   Israel, Dawn A ^a   Peek Jr , Richard M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CHRONIC GASTRITIS; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH EPITHELIUM;

APOPTOSIS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELLS, CULTURED; CYTOTOXINS; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MUTATION; VACUOLES;

EID: 0037373880     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Correa, P. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol. Biomark. Prev., 5: 477-481, 1996.
2. Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacey, A. R., Wald, N., and Sitas, F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ, 302: 1302-1305, 1991.
3. Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I., and Blaser, M. J. Helicobocter pylori infection and gastric carcinoma among Japanese Americans in Hawaii, N. Engl. J. Med., 325: 1132-1136, 1991.
4. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., and Sibley, R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med., 325: 1127-1131, 1991.
5. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., and Schlemper, R. J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med., 345: 784-789, 2001.
6. Peek, R. M., Jr., and Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer, 2: 28-37, 2002.
7. Watanabe, T., Tada, M., Nagai, H., Sasaki, S., and Nakao, M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology, 115: 642-648, 1998.
8. Honda, S., Fujioka, T., Tokieda, M., Satoh, R., Nishizono, A., and Nasu, M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res., 58: 4255-4259, 1998.
9. Cover, T. L., and Blaser, M. J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem., 267: 10570-10575, 1992.
10. Cover, T. L., Tummuru, M. K., Cao, P., Thompson, S. A., and Blaser, M. J. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem., 269: 10566-10573, 1994.
11. Telford, J. L., Ghiara, P., Dell'Orco, M., Comanducci, M., Burroni, D., Bugnoli, M., Tecce, M. F., Censini, S., Covacci, A., and Xiang, Z. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med., 179: 1653-1658, 1994.
12. Schmitt, W., and Haas, R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol. Microbiol., 12: 307-319, 1994.
13. Phadnis, S. H., Ilver, D., Janzon, L., Normark, S., and Westblom, T. U. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect. Immun., 62: 1557-1565, 1994.
14. Atherton, J. C., Cover, T. L., Papini, E., and Telford, J. L. Vacuolating cytotoxin. In: H. L. T. Mobley, G. L. Mendz, and S. L. Hazell (eds.), Helicobacter pylori: Physiology and Genetics, pp. 97-110. Washington DC: ASM Press, 2001.
15. Leunk, R. D., Johnson, P. T., David, B. C., Kraft, W. G., and Morgan, D. R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol., 26: 93-99, 1988.
16. Cover, T. L., Vaughn, S. G., Cao, P., and Blaser, M. J. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J. Infect. Dis., 166: 1073-1078, 1992.
17. Papini, E., de Bernard, M., Milia, E., Bugnoli, M., Zerial, M., Rappuoli, R., and Montecucco, C. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc. Natl. Acad. Sci. USA, 91: 9720-9724, 1994.
18. Molinari, M., Galli, C., Norais, N., Telford, J. L., Rappuoli, R., Luzio, J. P., and Montecucco, C. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J. Biol. Chem., 272: 25339-25344, 1997.
19. Ricci, V., Sommi, P., Fiocca, R., Romano, M., Solcia. E., and Ventura, U. Helicobacter pylori vacuolating toxin accumulates within the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia. J. Pathol., 183: 453-459, 1997.
20. Sommi, P., Ricci, V., Fiocca, R., Necchi, V., Romano, M., Telford, J. L., Solcia, E., and Ventura, U. Persistence of Helicobacter pylori VacA toxin and vacuolating potential in cultured gastric epithelial cells. Am. J. Physiol., 275: G681-G688, 1998.
21. McClain, M. S., Schraw, W., Ricci, V., Boquet, P., and Cover, T. L. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells. Mol. Microbiol., 37: 433-442, 2000.
22. Atherton, J. C., Cao, P., Peek, R. M., Jr., Tummuru, M. K., Blaser, M. I., and Cover, T. L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem., 270: 17771-17777, 1995.
23. van Doorn, L. J., Figueiredo, C., Sanna, R., Pena, S., Midolo, P., Ng, E. K., Atherton, J. C., Blaser, M. J., and Quint, W. G. Expanding allelic diversity of Helicobacter pylori vacA. J. Clin. Microbiol., 36: 2597-2603, 1998.
24. van Doorn, L. J., Figueiredo, C., Megraud, F., Pena, S., Midolo, P., Queiroz, D. M., Carneiro, F., Vanderborght, B., Pegado, M. D., Sanna, R., De Boer, W., Schneeberger, P. M., Correa, P., Ng, E. K., Atherton, J., Blaser, M. J., and Quint, W. G. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology, 116: 823-830, 1999.
25. Letley, D. P., and Atherton, J. C. Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity. J. Bacteriol., 182: 3278-3280, 2000.
26. McClain, M. S., Cao, P., Iwamoto, H., Vinion-Dubiel, A. D., Szabo, G., Shao, Z., and Cover, T. L. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J. Bacteriol., 183: 6499-6508, 2001.
27. Gerhard, M., Lehn, N., Neumayer, N., Boren, T., Rad, R., Schepp, W., Miehlke, S., Classen, M., and Prinz, C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. USA, 96: 12778-12783, 1999.
28. Miehlke, S., Kirsch, C., Agha-Amiri, K., Gunther, T., Lehn, N., Malfertheiner, P., Stolte, M., Ehninger, G., and Bayerdorffer, E. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer, 87: 322-327, 2000.
29. Louw, J. A., Kidd, M. S., Kummer, A. F., Taylor, K., Kotze, U., and Hanslo, D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter, 6: 268-273, 2001.
30. Figueiredo, C., Machado, J. C., Pharoah, P., Seruca, R., Sousa, S., Carvalho, R., Capelinha, A. F., Quint, W., Caldas, C., van Doom, L. J., Carneiro, F., and Sobrinho-Simoes, M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. (Bethesda), 94: 1680-1687, 2002.
31. Atherton, J. C., Peek, R. M., Jr., Tham, K. T., Cover, T. L., and Blaser, M. J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology, 112: 92-99, 1997.
32. Ghiara, P., Marchetti, M., Blaser, M. J., Tummuru, M. K., Cover, T. L., Segal, E. D., Tompkins, L. S., and Rappuoli, R. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect. Immun., 63: 4154-4160, 1995.
33. Moss, S. F., Calam, J., Agarwal, B., Wang, S., and Holt, P. R. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut, 38: 498-501, 1996.
34. Mannick, E. E., Bravo, L. E., Zarama, G., Realpe, J. L., Zhang, X. J., Ruiz, B., Fontham, E. T., Mera, R., Miller, M. J., and Correa, P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res., 56: 3238-3243, 1996.
35. Jones, N. L., Shannon, P. T., Cutz, E., Yeger, H., and Sherman, P. M. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am. J. Pathol., 151: 1695-1703, 1997.
36. Rudi, J., Kuck, D., Strand, S., von Herbay, A., Mariani, S. M., Krammer, P. H., Galle, P. R., and Stremmel, W. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J. Clin. Investig., 102: 1506-1514, 1998.
37. Wang, T. C., Goldenring, J. R., Dangler, C., Ito, S., Mueller, A., Jeon, W. K., Koh, T. J., and Fox, J. G. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter fells infection. Gastroenterology, 114: 675-689, 1998.
38. Houghton, J. M., Bloch, L. M., Goldstein, M., Von Hagen, S., and Korah, R. M. In vivo disruption of the Fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. J. Infect. Dis., 182: 856-864, 2000.
39. Jones, N. L., Day, A. S., Jennings, H., Shannon, P. T., Galindo-Mata, E., and Sherman, P. M. Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect. Immun., 70: 2591-2597, 2002.
40. Peek, R. M., Wirth, H. P., Moss, S. F., Yang, M., Abdalla, A. M., Tham, K. T., Zhang, T., Tang, L. H., Modlin, I. M., and Blaser, M. J. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology, 118: 48-59, 2000.
41. Israel, D. A., Salama, N., Arnold, C. N., Moss, S. F., Ando, T., Wirth, H. P., Tham, K. T., Camorlinga, M., Blaser, M. J., Falkow, S., and Peek, R. M., Jr. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Investig., 107: 611-620, 2001.
42. Fan, X., Gunasena, H., Cheng, Z., Espejo, R., Crowe, S. E., Ernst, P. B., and Reyes, V. E. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J. Immunol., 165: 1918-1924, 2000.
43. Peek, R. M., Jr., Blaser, M. J., Mays, D. J., Forsyth, M. H., Cover, T. L., Song, S. Y., Krishna, U., and Pietenpol, J. A. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res., 59: 6124-6131, 1999.
44. Kawahara, T., Teshima, S., Kuwano, Y., Oka, A., Kishi, K., and Rokutan, K. Helicobacter pylori lipopolysaccharide induces apoptosis of cultured guinea pig gastric mucosal cells. Am. J. Physiol. Gastrointest. Liver Physiol., 281: G726-G734, 2001.
45. Wagner, S., Beil, W., Westermann, J., Logan, R. P., Bock, C. T., Trautwein, C., Bleck, J. S., and Manns, M. P. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology, 113: 1836-1847, 1997.
46. Jones, N. L., Day, A. S., Jennings, H. A., and Sherman, P. M. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect. Immun., 67: 4237-4242, 1999.
47. Houghton, J., Korah, R. M., Condon, M. R., and Kim, K. H. Apoptosis in Helicobacter pylori-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway. Dig. Dis. Sci., 44: 465-478, 1999.
48. Gupta, R. A., Polk, D. B., Krishna, U., Israel, D. A., Yan, F., DuBois, R. N., and Peek, R. M., Jr. Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor κB-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J. Biol. Chem., 276: 31059-31066, 2001.
49. Kuck, D., Kolmerer, B., Iking-Konert, C., Krammer, P. H., Stremmel, W., and Rudi, J. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect. Immun., 69: 5080-5087, 2001.
50. Cover, T. L., Hanson, P. I., and Heuser, J. E. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J. Cell Biol., 138: 759-769, 1997.
51. Czajkowsky, D. M., Iwamoto, H., Cover, T. L., and Shao, Z. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc. Natl. Acad. Sci. USA, 96: 2001-2006, 1999.
52. Vinion-Dubiel, A. D., McClain, M. S., Czajkowsky, D. M., Iwamoto, H., Ye, D., Cao, P., Schraw, W., Szabo, G., Blanke, S. R., Shao, Z., and Cover, T. L. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation. J. Biol. Chem., 274: 37736-37742, 1999.
53. Tsuda, T., Karita, M., Morshed, M. G., Okita, K., and Nakazawa, T. A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect. Immun., 62: 3586-3589, 1994.
54. de Bernard, M., Papini, E., de Filippis, V., Gottardi, E., Telford, J., Manetti, R., Fontana, A., Rappuoli, R., and Montecucco, C. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J. Biol. Chem., 270: 23937-23940, 1995.
55. Forsyth, M. H., Atherton, J. C., Blaser, M. J., and Cover, T. L. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains. Infect. Immun., 66: 3088-3094, 1998.
56. Correa, P., Ruiz, B., Shi, T. Y., Janney, A., Sobhan, M., Torrado, J., and Hunter, F. Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am. J. Clin. Pathol., 101: 656-660, 1994.
57. Peek, R. M., Jr., Moss, S. F., Tham, K. T., Perez-Perez, G. I., Wang, S., Miller, G. G., Atherton, J. C., Holt, P. R., and Blaser, M. J. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl. Cancer Inst. (Bethesda), 89: 863-868, 1997.
58. Rokkas, T., Ladas, S., Liatsos, C., Petridou, E., Papatheodorou, G., Theocharis, S., Karameris, A., and Raptis, S. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig. Dis. Sci., 44: 487-493, 1999.
59. Hirasawa, R., Tatsuta, M., Iishi, H., Yano, H., Baba, M., Uedo, N., and Sakai, N. Increase in apoptosis and decrease in omithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori. Am. J. Gastroenterol., 94: 2398-2402, 1999.
60. Keates, S., Hitti, Y. S., Upton, M., and Kelly, C. P. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology, 113: 1099-1109, 1997.
61. Sharma, S. A., Tummuru, M. K., Blaser, M. J, and Kerr, L. D. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-κB in gastric epithelial cells. J. Immunol., 160: 2401-2407, 1998.
62. Maeda, S., Yoshida, H., Ogura, K., Mitsuno, Y., Hirata, Y., Yamaji, Y., Akanuma, M., Shiratori, Y., and Omata, M. H. pylori activates NF-κB through a signaling pathway involving IκB kinases. NF-κB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology, 119: 97-108, 2000.
63. Crabtree, J. E., and Lindley, I. J. Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease. Eur. J. Gastroenterol. Hepatol., 6 (Suppl. 1): S33-S38, 1994.
64. Galmiche, A., Rassow, J., Doye, A., Cagnol, S., Chambard, J. C., Contamin, S., de Thillot, V., Just, I., Ricci, V., Solcia, E., Van Obberghen, E., and Boquet, P. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J., 19: 6361-6370, 2000.
65. Ashktorab, H., Neapolitano, M., Bomma, C., Allen, C., Ahmed, A., Dubois, A., Naab, T., and Smoot, D. T. In vivo and in vitro activation of caspase-8 and -3 associated with Helicobacter pylori infection. Microbes Infect., 4: 713-722, 2002.
66. Bantel, H., Sinha, B., Domschke, W., Peters, G., Schulze-Osthoff, K., and Janicke, R. U. α-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J. Cell Biol., 155: 637-648, 2001.
67. Igarashi, M., Kitada, Y., Yoshiyama, H., Takagi, A., Miwa, T., and Koga, Y. Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection. Infect. Immun., 69: 816-821, 2001.
68. Suzuki, H., Yanaka, A., Shibahara, T., Matsui, H., Nakahara, A., Tanaka, N., Muto, H., Momoi, T., and Uchiyama, Y. Ammonia-induced apoptosis is accelerated at higher pH in gastric surface mucous cells. Am. J. Physiol. Gastrointest. Liver Physiol., 283: G986-G995, 2002.
69. Dunn, B. E., Campbell, G. P., Perez-Perez, G. I., and Blaser, M. J. Purification and characterization of urease from Helicobacter pylori. J. Biol. Chem., 265: 9464-9469, 1990.
70. Engstrand, L., Scheynius, A., Pahlson, C., Grimelius, L., Schwan, A., and Gustavsson, S. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect. Immun., 57: 827-832, 1989.
71. Wang, J., Fan, X., Lindholm, C., Bennett, M., O'Connoll, J., Shanahan, F., Brooks, E. G., Reyes, V. E., and Ernst, P. B. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions. Infect. Immun., 68: 4303-4311, 2000.
72. Smythies, L. E., Waites, K. B., Lindsey, J. R., Harris, P. R., Ghiara, P., and Smith, P. D. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J. Immunol., 165: 1022-1029, 2000.
73. Noach, L. A., Bosma, N. B., Jansen, J., Hoek, F. J., van Deventer, S. J., and Tytgat, G. N. Mucosal tumor necrosis factor-αs, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol., 29: 425-429, 1994.
74. El-Omar, E. M., Carrington, M., Chow, W. H., McColl, K. E., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C. C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J. F., Jr., and Rabkin. C. S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (Lond.), 404: 398-402, 2000.
75. Sipponen, P., and Marshall, B. J. Gastritis and gastric cancer. Western countries. Gastroenterol. Clin. North Am., 29: 579-592, 2000.
76. Correa, P., and Miller, M. J. Carcinogenesis, apoptosis and cell proliferation. Br. Med. Bull., 54: 151-162, 1998.